ArticleCardiovascular diabetology2018

Cardiovascular benefit in the limelight: shifting type 2 diabetes treatment paradigm towards early combination therapy in patients with overt cardiovascular disease.

Naim Shehadeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.